These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33137262)

  • 41. Codon-usage frequency mediated SNPs selection in lasR gene of cystic fibrosis Pseudomonas aeruginosa isolates.
    Qiu H; Li Y; Dai W
    Microbiol Res; 2019; 223-225():137-143. PubMed ID: 31178047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung.
    Ballok AE; O'Toole GA
    J Bacteriol; 2013 Sep; 195(18):4013-9. PubMed ID: 23836869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
    Ernst RK; Yi EC; Guo L; Lim KB; Burns JL; Hackett M; Miller SI
    Science; 1999 Nov; 286(5444):1561-5. PubMed ID: 10567263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P. aeruginosa blood stream infection isolates: A "full house" of virulence genes in isolates associated with rapid patient death and patient survival.
    McCarthy KL; Wailan AM; Jennison AV; Kidd TJ; Paterson DL
    Microb Pathog; 2018 Jun; 119():81-85. PubMed ID: 29621565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
    Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR
    J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis.
    Deretic V; Schurr MJ; Yu H
    Trends Microbiol; 1995 Sep; 3(9):351-6. PubMed ID: 8520888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DeaD contributes to Pseudomonas aeruginosa virulence in a mouse acute pneumonia model.
    Tan H; Zhang L; Zhao Q; Chen R; Liu C; Weng Y; Peng Q; Bai F; Cheng Z; Jin S; Wu W; Jin Y
    FEMS Microbiol Lett; 2016 Oct; 363(20):. PubMed ID: 27682417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.
    Manos J; Hu H; Rose BR; Wainwright CE; Zablotska IB; Cheney J; Turnbull L; Whitchurch CB; Grimwood K; Harmer C; Anuj SN; Harbour C;
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1583-92. PubMed ID: 23832143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.
    Mena A; Maciá MD; Borrell N; Moya B; de Francisco T; Pérez JL; Oliver A
    J Bacteriol; 2007 May; 189(9):3665-8. PubMed ID: 17307847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.
    Marvig RL; Sommer LM; Jelsbak L; Molin S; Johansen HK
    Future Microbiol; 2015; 10(4):599-611. PubMed ID: 25865196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections.
    Imamovic L; Ellabaan MMH; Dantas Machado AM; Citterio L; Wulff T; Molin S; Krogh Johansen H; Sommer MOA
    Cell; 2018 Jan; 172(1-2):121-134.e14. PubMed ID: 29307490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rapid
    Wang K; Chen YQ; Salido MM; Kohli GS; Kong JL; Liang HJ; Yao ZT; Xie YT; Wu HY; Cai SQ; Drautz-Moses DI; Darling AE; Schuster SC; Yang L; Ding Y
    Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878043
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Høiby N; Espersen F; Koch C
    Thorax; 1992 Jan; 47(1):6-13. PubMed ID: 1539148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.
    Carterson AJ; Morici LA; Jackson DW; Frisk A; Lizewski SE; Jupiter R; Simpson K; Kunz DA; Davis SH; Schurr JR; Hassett DJ; Schurr MJ
    J Bacteriol; 2004 Oct; 186(20):6837-44. PubMed ID: 15466037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients.
    Son MS; Matthews WJ; Kang Y; Nguyen DT; Hoang TT
    Infect Immun; 2007 Nov; 75(11):5313-24. PubMed ID: 17724070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chimeric Protein-Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and
    Ngo TD; Plé S; Thomas A; Barette C; Fortuné A; Bouzidi Y; Fauvarque MO; Pereira de Freitas R; Francisco Hilário F; Attrée I; Wong YS; Faudry E
    ACS Infect Dis; 2019 Nov; 5(11):1843-1854. PubMed ID: 31525902
    [No Abstract]   [Full Text] [Related]  

  • 60. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.
    Phennicie RT; Sullivan MJ; Singer JT; Yoder JA; Kim CH
    Infect Immun; 2010 Nov; 78(11):4542-50. PubMed ID: 20732993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.